Insider Selling: ReposiTrak (NYSE:TRAK) CEO Sells 3,000 Shares of Stock

ReposiTrak Inc. (NYSE:TRAKGet Free Report) CEO Randall Fields sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $8.82, for a total transaction of $26,460.00. Following the transaction, the chief executive officer owned 107,500 shares in the company, valued at $948,150. This represents a 2.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

ReposiTrak Stock Down 2.9%

TRAK traded down $0.26 during trading on Friday, reaching $8.73. The stock had a trading volume of 116,394 shares, compared to its average volume of 88,100. The stock has a 50 day moving average of $11.47 and a two-hundred day moving average of $14.07. The firm has a market capitalization of $158.89 million, a price-to-earnings ratio of 23.59 and a beta of 0.45. ReposiTrak Inc. has a 1-year low of $8.69 and a 1-year high of $23.72.

ReposiTrak (NYSE:TRAKGet Free Report) last issued its quarterly earnings results on Tuesday, February 17th. The company reported $0.09 earnings per share (EPS) for the quarter. The company had revenue of $5.86 million for the quarter. ReposiTrak had a return on equity of 14.52% and a net margin of 30.62%.

Institutional Investors Weigh In On ReposiTrak

A number of institutional investors have recently bought and sold shares of the business. XTX Topco Ltd purchased a new position in ReposiTrak during the 4th quarter valued at about $214,000. Occudo Quantitative Strategies LP acquired a new stake in shares of ReposiTrak during the fourth quarter worth approximately $147,000. Price T Rowe Associates Inc. MD boosted its holdings in shares of ReposiTrak by 23.8% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 28,094 shares of the company’s stock worth $348,000 after purchasing an additional 5,400 shares during the period. Rice Hall James & Associates LLC grew its position in ReposiTrak by 6.4% during the fourth quarter. Rice Hall James & Associates LLC now owns 793,858 shares of the company’s stock valued at $9,820,000 after purchasing an additional 47,914 shares in the last quarter. Finally, Squarepoint Ops LLC increased its stake in ReposiTrak by 39.5% in the 4th quarter. Squarepoint Ops LLC now owns 99,830 shares of the company’s stock valued at $1,235,000 after buying an additional 28,282 shares during the period. 27.35% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on TRAK shares. Weiss Ratings restated a “hold (c+)” rating on shares of ReposiTrak in a report on Monday, December 29th. Wall Street Zen cut ReposiTrak from a “buy” rating to a “hold” rating in a research note on Saturday, January 17th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock has an average rating of “Hold”.

View Our Latest Stock Analysis on ReposiTrak

About ReposiTrak

(Get Free Report)

ReposiTrak, trading on the New York Stock Exchange under the symbol TRAK, is a provider of cloud-based supply chain compliance and transparency solutions. The company’s platform enables retailers, suppliers and manufacturers to manage, share and validate product data throughout the supply chain. Through its Software-as-a-Service (SaaS) offering, ReposiTrak helps organizations ensure adherence to regulatory requirements, industry standards and retailer-specific guidelines for food safety, sustainability, labeling and quality assurance.

At the core of ReposiTrak’s offerings is its DataHub, a centralized repository that captures critical information such as product specifications, certifications, catch-weight data, temperature logs and recall notifications.

Recommended Stories

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

Receive News & Ratings for ReposiTrak Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReposiTrak and related companies with MarketBeat.com's FREE daily email newsletter.